Dr. Michael Drew was elected to full member stats in the American College of Neuropsychopharmacology (ANCP).
The American College of Neuropsychopharmacology is an international organization of leading brain scientists. Sceintists are selected for membershipon the basis of their original research contributions, and are drawn from diverse subfields of neuroscience, including behavioral pharmacology, clinical psychopharmacology, epidemiology, genetics, molecular biology, neurochemistry, neuroendocrinology, neuroimaging, neuroimmunology, neurophysiology, neurology, psychiatry, and psychology.
The principal functions of the College are research and education. ACNP research goals are to offer investigators the opportunity for cross-disciplinary communication, and to promote the application of various neuroscientific disciplines to the study of all forms of mental illness and their treatment. ACNP educational goals are to encourage young scientists to enter research careers in neuropsychopharmacology and to develop and provide accurate information about psychiatric disorders and treatment. ACNP members represent a collective expertise in the science of psychiatric disorders from the standpoint of diagnostics and therapeutics and are consistently acclaimed as the thought leaders in psychiatry and pharmacology.
